The AKR1B1 gene gives your cells instructions to make aldose reductase, an enzyme that helps process certain sugars and clear some harmful chemical byproducts. This gene helps your body manage chemical stress, especially when blood sugar is high. If the gene does not work normally, cells may handle sugar and these byproducts less well, and extra activity in this pathway has been linked to diabetic eye, nerve, and kidney complications. Most AKR1B1 variants have little effect on health, while some may slightly change risk.
What is a gene?
Genes are sections of DNA that give cells instructions for making molecules or managing processes in the body. Some carry the information needed to produce proteins, the working parts of cells. Others mainly regulate when certain processes happen, where they happen, and how strongly they run. Taken together, genes affect how the body develops and functions, and they can also shape your response to food, stress, and medications. To go further into this subject, more information is available in the LearnHub.
Overview
AKR1B1Gene function
What if the gene works
The AKR1B1 gene helps cells process some sugars and clear certain reactive chemicals. Its protein is active in tissues such as the lens, nerves, kidneys, and blood vessels.
Risk
What if the gene does not work
Milder to more severe variants in the AKR1B1 gene can reduce how well cells process certain sugars and damaging chemical byproducts. This can alter sorbitol production and weaken part of the cell's stress response.
Treatment
What does that mean for your treatment
No AKR1B1-specific treatment or management approach is currently established for people with a pathogenic or loss-of-function variant in the AKR1B1 gene. AKR1B1 is being studied as a drug target, especially through aldose reductase inhibitors for diabetes-related eye, nerve, and kidney complications, but this is not a guideline-based treatment for AKR1B1 variants themselves.
Conditions associated with AKR1B1
Gene function
What if the gene works
Understanding how the AKR1B1 gene helps process sugar in cells starts with its everyday chemical work. Your cells use this gene to convert certain small compounds made from sugars and fats into forms that are easier to handle. This supports steady metabolism and helps routine cell activity run smoothly.
As part of normal sugar handling, the AKR1B1 gene helps turn some glucose into sorbitol. This is a routine step in the polyol pathway, a cell process that gives tissues another way to manage sugars.
Its protein converts reactive aldehydes, small chemicals that can form when sugars and fats are processed, into less reactive alcohols. This helps cells keep everyday chemical byproducts under control.
What is a variant?
A genetic variant is a small difference in the DNA sequence within a gene. These changes are common and are part of normal human diversity, such as differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some cases, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the AKR1B1 gene can change how much aldose reductase a cell makes or how well the enzyme folds and works. In plain terms, how AKR1B1 variants affect aldose reductase activity depends on where the DNA change sits: some alter control regions, while others weaken binding to NADPH (a helper molecule the enzyme needs) or its target compounds. Milder variants may only partly reduce activity, while more severe variants can leave the protein unstable or largely inactive.
How variants are linked to conditions
Variants in the AKR1B1 gene do not yet have a broadly confirmed link to a specific health condition, although research on AKR1B1 gene variants and health conditions is still developing. Anyone with a confirmed AKR1B1-related finding should rely on guidance from their doctor or genetic counselor rather than general information.
A variant is not necessarily a diagnosis
Variants in genes are a usual feature of human biology and are widely found across the population. Most do not directly affect health and instead represent normal human variation. For many genes, having a variant associated with a condition points to a potential link, not a certain diagnosis, particularly when several genes and environmental influences also play a role. In some situations, though, one well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For AKR1B1, any effect on health risk appears to be most relevant in people living with diabetes, especially for eye, nerve, and kidney complications. Risk is also shaped by everyday factors such as how long diabetes has been present and how well blood sugar and blood pressure are controlled, so AKR1B1 changes do not act alone.
Inheritance of AKR1B1 variants
For families trying to understand how AKR1B1 gene variants are inherited, there is not yet a broadly confirmed Mendelian inheritance pattern tied to a specific AKR1B1 related condition. Most reported AKR1B1 findings are linked to differences in risk rather than a single inherited condition with a clear autosomal dominant, autosomal recessive, or X linked pattern. The AKR1B1 gene is located on chromosome 7, which is an autosome, so each person inherits one copy from each parent.
What does my AKR1B1 result mean for my family?
There is not yet a broadly confirmed family inheritance pattern tied to a specific condition for AKR1B1. If you have a specific AKR1B1 result and want to understand what it could mean for close relatives, a doctor or genetic counselor can help interpret it in the context of your personal and family history.
Genetic information
Genetic testing
How you find out about variants
AKR1B1 genetic testing usually uses a blood or saliva sample, and the lab reads the DNA in the AKR1B1 gene to look for variants. This may be done as a single-gene test or as part of a larger panel, exome, or genome test, depending on why testing is being done. Results show whether a variant was found.
When should I consider getting a genetic test?
There is not yet a widely accepted, AKR1B1-specific medical reason for routine genetic testing. Testing decisions are usually made with a doctor or genetic counselor based on your personal health, family history, and any related findings such as diabetes complications.
A genetic result is only one part of your health story
Genetic results can provide useful insight, but how much they reveal varies with the condition and the kind of variant present. Over time, many factors shape how the body works, including lifestyle, environment, age, and medical history. In some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is best considered alongside other parts of care. In other situations, a genetic result can give a clear answer. In areas like medication response, genetic findings can help put personal experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body breaks down a drug, moves it through the bloodstream, or how strongly the drug acts on its target. This helps explain why the same treatment works well for one person, seems weaker for another, or causes more side effects in someone who is more sensitive to it.
What is Pharmacogenetics?
Pharmacogenetics is the study of how differences in genes affect the way a person responds to medications. It examines connections between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes influence how strongly a drug works or how the body handles it. This information can support treatment decisions that are more informed and more individualized. If you want to learn more about this topic, additional information is available in the LearnHub.
Drugs influenced by the AKR1B1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choice or dose, so general questions about side effects, treatment changes, or new symptoms are best discussed with your doctor. Research on the AKR1B1 gene has looked at possible links with response to some diabetes-related treatments, but this is not used routinely in care.
History
AKR1B1 entered medical research through studies of a protein later called aldose reductase, identified in the mid 20th century as scientists traced how the body handles certain sugars. In the 1960s and 1970s, this line of work became closely tied to research on diabetes complications, especially eye, nerve, and kidney changes. Initially understood only through visible traits, later recognized as tied to a specific gene, AKR1B1 became part of a broader effort to explain why high blood sugar can damage tissues over time. From these first observations, research expanded steadily. By the 1980s and 1990s, the AKR1B1 gene was being studied both as a treatment target and as a possible source of inherited differences in risk, helping shape modern diabetic complication research.